Literature DB >> 6390022

Is schizophrenia an autoimmune disease? A review.

J G Knight.   

Abstract

Autoimmunity has been shown to be the basis of an ever-increasing number of human diseases. Schizophrenia shares a number of genetic features with these autoimmune diseases and therefore could be an autoimmune disease itself. Several lines of evidence suggest that overactivity of dopaminergic pathways in some areas of the brain are involved in schizophrenia, but the apparent absence of an increase in dopamine turnover suggests that this hyperactivity could be mediated by a dopamine agonist rather than by dopamine itself. Schizophrenia is reviewed in the light of precedents from the field of autoimmune diseases in which autoantibodies have been shown to be able to interact with, and sometimes stimulate hormone receptors, thereby causing disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6390022

Source DB:  PubMed          Journal:  Methods Find Exp Clin Pharmacol        ISSN: 0379-0355


  6 in total

1.  Immune System and Schizophrenia.

Authors:  Norbert Müller; Markus J Schwarz
Journal:  Curr Immunol Rev       Date:  2010-08

2.  Blood-cerebrospinal fluid barrier in schizophrenic patients.

Authors:  K Bauer; J Kornhuber
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1987

3.  Anti-CNS antibodies in neurological and psychiatric disorders.

Authors:  A V Plioplys; J Thibault; J P Bouchard; C Cockburn; R Hawkes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-11       Impact factor: 10.154

4.  Use of a Gluten-Free Diet in Schizophrenia: A Systematic Review.

Authors:  Anastasia Levinta; Ilya Mukovozov; Christopher Tsoutsoulas
Journal:  Adv Nutr       Date:  2018-11-01       Impact factor: 8.701

5.  Association analysis of heat shock protein 70 gene polymorphisms in schizophrenia.

Authors:  Jung Jin Kim; Laura Mandelli; Suzy Lim; Hyun Kook Lim; Oh Joo Kwon; Chi Un Pae; Alessandro Serretti; Vishwajit L Nimgaonkar; In-Ho Paik; Tae-Youn Jun
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06       Impact factor: 5.270

6.  Anthranilic Acid: A Potential Biomarker and Treatment Target for Schizophrenia.

Authors:  Gregory Oxenkrug; Marieke van der Hart; Julien Roeser; Paul Summergrad
Journal:  Ann Psychiatry Ment Health       Date:  2016-01-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.